Germany - Vaccines For Human Medicine - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingVaccine Price in Germany - 2021
Contents:
- Vaccine Price in Germany (FOB) - 2022
- Vaccine Price in Germany (CIF) - 2021
- Vaccine Exports in Germany
- Vaccine Imports in Germany
Vaccine Price in Germany (FOB) - 2022
The average vaccine export price stood at $1,294,394 per ton in 2022, growing by 75% against the previous year. Over the period under review, the export price continues to indicate a resilient expansion. As a result, the export price reached the peak level and is likely to continue growth in the immediate term.
There were significant differences in the average prices for the major export markets. In 2022, amid the top suppliers, the country with the highest price was Turkey ($4,985,282 per ton), while the average price for exports to Slovakia ($185,876 per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Turkey (+41.3%), while the prices for the other major destinations experienced more modest paces of growth.
Vaccine Price in Germany (CIF) - 2021
The average vaccine import price stood at $9.0M per ton in November 2021, surging by 8.2% against the previous month. Overall, the import price saw buoyant growth. The pace of growth appeared the most rapid in March 2021 an increase of 159% m-o-m. The import price peaked at $18.8M per ton in June 2021; afterwards, it flattened through to November 2021.
There were significant differences in the average prices amongst the major supplying countries. In November 2021, the country with the highest price was Belgium ($24.6M per ton), while the price for France ($293K per ton) was amongst the lowest.
From November 2020 to November 2021, the most notable rate of growth in terms of prices was attained by Italy (+24.7%), while the prices for the other major suppliers experienced more modest paces of growth.
Vaccine Exports in Germany
For the third consecutive year, Germany recorded decline in overseas shipments of vaccines for human medicine, which decreased by -20.5% to 340 tons in 2022. Over the period under review, exports faced a precipitous decline. The smallest decline of -13.1% was in 2020.
In value terms, vaccine exports soared to $441M in 2022. Overall, exports continue to indicate a abrupt slump.
| Export of Vaccine in Germany (Million USD) | |||||
|---|---|---|---|---|---|
| COUNTRY | 2019 | 2020 | 2021 | 2022 | CAGR, 2019-2022 |
| France | 26.4 | 52.9 | 39.4 | 67.5 | 36.7% |
| Italy | 7.5 | 16.1 | 36.8 | 63.0 | 103.3% |
| Turkey | 1.0 | 0.6 | 33.0 | 56.5 | 283.7% |
| Spain | 9.1 | 9.2 | 24.3 | 41.7 | 66.1% |
| Poland | 3.3 | 9.2 | 22.4 | 38.4 | 126.6% |
| Belgium | 379 | 224 | 8.0 | 13.7 | -66.9% |
| United States | 168 | 131 | 5.8 | 9.9 | -61.1% |
| Hungary | 0.1 | 1.1 | 4.9 | 8.4 | 338.0% |
| Singapore | 3.2 | 0.7 | 4.4 | 7.5 | 32.8% |
| Slovakia | 0.1 | 1.1 | 2.5 | 4.3 | 250.3% |
| Lithuania | 0.2 | 0.6 | 1.9 | 3.2 | 152.0% |
| United Kingdom | 31.3 | 58.8 | 1.8 | 3.1 | -53.7% |
| Slovenia | 0.2 | 0.4 | 1.2 | 2.0 | 115.4% |
| Others | 52.9 | 60.0 | 130 | 121 | 31.8% |
| Total | 682 | 565 | 316 | 441 | -13.5% |
Top Export Markets for Vaccine from Germany in 2022:
- Italy (100.9 tons)
- Poland (44.2 tons)
- Belgium (24.6 tons)
- Slovakia (22.9 tons)
- France (19.2 tons)
- Singapore (15.3 tons)
- Hungary (15.2 tons)
- Turkey (11.3 tons)
- Spain (10.6 tons)
- Lithuania (10.5 tons)
- United Kingdom (9.8 tons)
- United States (9.1 tons)
- Slovenia (7.3 tons)
Vaccine Imports in Germany
In 2022, the amount of vaccines for human medicine imported into Germany contracted markedly to 2.1K tons, which is down by -48.2% compared with the year before. Overall, imports, however, posted a buoyant expansion. The most prominent rate of growth was recorded in 2021 when imports increased by 292% against the previous year. As a result, imports attained the peak of 4.1K tons, and then fell markedly in the following year.
In value terms, vaccine imports dropped notably to $5.2B in 2022. Over the period under review, imports, however, continue to indicate a significant increase. The most prominent rate of growth was recorded in 2021 with an increase of 424% against the previous year. As a result, imports attained the peak of $8.8B, and then shrank rapidly in the following year.
| Import of Vaccine in Germany (Million USD) | |||||
|---|---|---|---|---|---|
| COUNTRY | 2019 | 2020 | 2021 | 2022 | CAGR, 2019-2022 |
| Belgium | 499 | 582 | 6,692 | 3,969 | 99.6% |
| Italy | 1.0 | 1.3 | 641 | 380 | 624.3% |
| Poland | 468 | 555 | 530 | 314 | -12.5% |
| France | 132 | 147 | 348 | 206 | 16.0% |
| Netherlands | 239 | 173 | 221 | 131 | -18.2% |
| Spain | 91.0 | 91.3 | 102 | 60.4 | -12.8% |
| Hungary | 4.3 | 4.7 | 46.4 | 27.5 | 85.6% |
| Others | 173 | 121 | 206 | 142 | -6.4% |
| Total | 1,608 | 1,675 | 8,786 | 5,231 | 48.2% |
Top Suppliers of Vaccine to Germany in 2022:
- Belgium (861.9 tons)
- Poland (417.1 tons)
- Hungary (258.2 tons)
- Italy (143.3 tons)
- Netherlands (126.9 tons)
- France (113.5 tons)
- Spain (102.8 tons)
This report provides an in-depth analysis of the vaccine market in Germany. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21202140 -
- Prodcom 21202145 - Vaccines for human medicine
Country coverage:
- Germany
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in Germany
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
642
This report provides an in-depth analysis of the vaccine market in Germany.
552
This report provides an in-depth analysis of the antisera market in Germany.
417
This report provides an in-depth analysis of the biological product market in Germany.
418
This report provides an in-depth analysis of the market for human and animal blood in Germany.
378
This report provides an in-depth analysis of the veterinary medicine vaccines market in Germany.
2853
This report provides an in-depth analysis of the global vaccine market.
2296
This report provides an in-depth analysis of the global antisera market.
562
This report provides an in-depth analysis of the global biological product market.
651
This report provides an in-depth analysis of the global market for human and animal blood.
756
This report provides an in-depth analysis of the global veterinary medicine vaccines market.
83
As a result, Antisera exports reached their peak and are expected to keep growing in the near future. In terms of value, Antisera exports surged to $4.7B in November 2023.
137
The highest growth rate was observed in November 2022, with a month-on-month increase of 24%. In terms of value, exports of Antisera significantly declined to $2B in October 2023.
67
Between 2022 and 2023, the growth of exports for Biological Products remained subdued, but their value rose significantly to $43.3B in 2023.
601
Due to widespread Covid vaccination rates, the global trade in vaccines reached $42.5B, the highest level ever. Belgium topped the country rankings by the value of exports this year, followed by Germany and the U.S. Growing global demand stimulates the rapid expansion of Covid vaccine production facilities in the EU.
1233
Belgium dominates in the global trade of vaccines for human medicine. In 2014, Belgium exported X tons of vaccines for human medicine totaling $X, X% over the previous year. Its primary trading partner was France, where it supplied X% o
285
Explore the top import markets for antisera and their key statistics. Find out which countries dominate the global import market for antisera and their import values.
1171
Global trade in antisera and other blood fractions reached the highest level ever, totalling near $182B in 2020. The U.S., Germany, China, Spain, the UK and South Korea top the world’s largest antisera exporter ranking, comprising 67% of the total shipments. More than half of antisera imports are supplied to Germany, the U.S., Austria, Spain, Italy, China and Switzerland.
1083
In 2016, the antisera and other blood fractions market grew by X% to X billion USD. From 2007 to 2016, the global value of consumption of antisera and other blood fractions almost doubled, which was due to the rising demand in developing countries.
1267
In 2016, the global imports of antisera stood at X tons, moving up by X% against the previous year figure. Overall, antisera imports continue to indicate an outstanding expansion. The most prom...
1273
In 2016, the global imports of antisera stood at X tons, moving up by X% against the previous year figure. Overall, antisera imports continue to indicate an outstanding expansion. The most prom...
